This compound is primarily used in the development of antibiotics, particularly in the synthesis of fluoroquinolone derivatives. It exhibits potent antibacterial activity by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and repair. Its structure allows for broad-spectrum efficacy against both Gram-positive and Gram-negative bacteria, making it valuable in treating respiratory, urinary tract, and skin infections. Additionally, its unique cyclopropyl and piperazine groups enhance its pharmacokinetic properties, improving absorption and tissue penetration. Research also explores its potential in combating antibiotic-resistant strains, contributing to the ongoing fight against microbial resistance.